This is a Validated Antibody Database (VAD) review about rhesus mac.. IL2, based on 25 published articles (read how Labome selects the articles), using IL2 antibody in all methods. It is aimed to help Labome visitors find the most suited IL2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IL2 synonym: IL-2

others
  • flow cytometry; human; loading ...; fig 6d
 IL2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 6d). Nature (2019) ncbi
 IL2 antibody (BioLegend, MQ1-17H12) was used . J Immunol (2019) ncbi
 IL2 antibody (BioLegend, MQ1-17H12) was used . Sci Rep (2018) ncbi
BioLegend
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; 1:200; loading ...; fig s5
BioLegend IL2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples at 1:200 (fig s5). J Clin Invest (2020) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BioLegend IL2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples . J Immunother Cancer (2020) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 6d
BioLegend IL2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 6d). Nature (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 1b
BioLegend IL2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 1b). J Immunol (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 3e
BioLegend IL2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 3e). J Exp Med (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 1b
BioLegend IL2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 1b). J Virol (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; 1:100; loading ...; fig 2e
BioLegend IL2 antibody (Biolegend, 500328) was used in flow cytometry on human samples at 1:100 (fig 2e). Nat Med (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 4c
BioLegend IL2 antibody (BioLegend, 500310) was used in flow cytometry on human samples (fig 4c). J Clin Invest (2018) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 6b
BioLegend IL2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 6b). Sci Rep (2018) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig s2b
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend IL2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples (fig s2b). Nature (2017) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend IL2 antibody (BioLegend, 500331) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...; fig 3a
In order to study CXCR5+ CD8 T cells in SIV-infected animals, BioLegend IL2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on rhesus macaque samples (fig 3a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (MQ1-17H12)
  • ELISA; human; loading ...; fig 4e
  • ELISA; mouse; loading ...; fig 5a
In order to identify protein arginine methyltransferase 5 as an important modulator of CD4(+) T cell expansion, BioLegend IL2 antibody (BioLegend, 500302) was used in ELISA on human samples (fig 4e) and in ELISA on mouse samples (fig 5a). J Immunol (2017) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...; tbl 1
In order to establish the ability of the herpes simplex virus-1 VC2 vaccine to elicit immune responses in rhesus macaques, BioLegend IL2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on rhesus macaque samples (tbl 1). Vaccine (2017) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BioLegend IL2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 5a
BioLegend IL2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples (fig 5a). Cytokine (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend IL2 antibody (BioLegend, 500331) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 3a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend IL2 antibody (biolegend, MQ1-17H12) was used in flow cytometry on human samples (fig 3a). J Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • immunocytochemistry; human; fig 6
BioLegend IL2 antibody (BioLegend, MQ1-17H12) was used in immunocytochemistry on human samples (fig 6). J Hematol Oncol (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BioLegend IL2 antibody (Biolegend, clone MQ1-17H12) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; 2 ul/test
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, BioLegend IL2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples at 2 ul/test. J Immunol Methods (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BioLegend IL2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BioLegend IL2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples . Med Microbiol Immunol (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BioLegend IL2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 4
BioLegend IL2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 4). J Immunol (2014) ncbi
Articles Reviewed
  1. Cao W, Fang F, Gould T, Li X, Kim C, Gustafson C, et al. Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation. J Clin Invest. 2020;130:3422-3436 pubmed publisher
  2. Marotte L, Simon S, Vignard V, Dupré E, Gantier M, Cruard J, et al. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. J Immunother Cancer. 2020;8: pubmed publisher
  3. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  4. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  5. Canete P, Sweet R, Gonzalez Figueroa P, Papa I, Ohkura N, Bolton H, et al. Regulatory roles of IL-10-producing human follicular T cells. J Exp Med. 2019;: pubmed publisher
  6. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed publisher
  7. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed publisher
  8. Kuranda K, Jean Alphonse P, Leborgne C, Hardet R, Collaud F, Marmier S, et al. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. J Clin Invest. 2018;128:5267-5279 pubmed publisher
  9. Zhang C, Peng Y, Hublitz P, Zhang H, Dong T. Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy. Sci Rep. 2018;8:5549 pubmed publisher
  10. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  11. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  12. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  13. Webb L, Amici S, Jablonski K, Savardekar H, Panfil A, Li L, et al. PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis. J Immunol. 2017;198:1439-1451 pubmed publisher
  14. Stanfield B, Pahar B, Chouljenko V, Veazey R, Kousoulas K. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. Vaccine. 2017;35:536-543 pubmed publisher
  15. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  16. Xie L, Zhou F, Liu X, Fang Y, Yu Z, Song N, et al. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease. Cytokine. 2016;85:37-44 pubmed publisher
  17. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  18. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  19. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  20. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  21. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  22. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed publisher
  23. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed publisher
  24. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed publisher
  25. Hebel K, Weinert S, Kuropka B, Knolle J, Kosak B, Jorch G, et al. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J Immunol. 2014;192:5160-70 pubmed publisher